0.00Open0.05Pre Close0 Volume12 Open Interest64.00Strike Price0.00Turnover87.30%IV16.36%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0186Delta0.0064Gamma1529.10Leverage Ratio-0.0316Theta-0.0002Rho-28.49Eff Leverage0.0037Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet